IL-17 and intestinal tumorigenesis

Drug Discovery Today: Disease Mechanisms

Volumn 8, Issue 3-4, 2011, Pages

  Chae, Wook Jin ^a   Bothwell, Alfred L M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; APC PROTEIN; AXIN; BETA CATENIN; CD133 ANTIGEN; GAMMA INTERFERON; GLYCOGEN SYNTHASE KINASE 3BETA; HERMES ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 17 ANTIBODY; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 17F; STAT3 PROTEIN; TUMOR NECROSIS FACTOR;

BREAST CANCER; CANCER GROWTH; CARCINOGENESIS; CD4+ T LYMPHOCYTE; COLON POLYPOSIS; COLORECTAL CANCER; HUMAN; INTESTINE CANCER; INTESTINE CARCINOGENESIS; LIVER CANCER; MYELOMA; NONHUMAN; OVARY CARCINOMA; PROTEIN ANALYSIS; REGULATORY T LYMPHOCYTE; REVIEW; SKIN CANCER; STOMACH CANCER; TH17 CELL;

EID: 84860344672     PISSN: None     EISSN: 17406765     Source Type: Journal    
DOI: 10.1016/j.ddmec.2011.11.001     Document Type: Review

References (40)

1. Jemal, A. et al. (2008) Cancer statistics, 2008. CA Cancer J. Clin. 58, 71-96
2. Markowitz, S.D. and Bertagnolli, M.M. (2009) Molecular origins of cancer: molecular basis of colorectal cancer. N. Engl. J. Med. 361, 2449-2460
3. Bronner, C.E. et al. (1994) Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 368, 258-261
4. Goss, K.H. and Groden, J. (2000) Biology of the adenomatous polyposis coli tumor suppressor. J. Clin. Oncol. 18, 1967-1979 (Pubitemid 30261936)
5. McCartney, B.M. and Nathke, I.S. (2008) Cell regulation by the Apc protein Apc as master regulator of epithelia. Curr. Opin. Cell Biol. 20, 186-193
6. Lynch, H.T. et al. (2008) Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management. Fam. Cancer 7, 27-39
7. Su, L.K. et al. (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256, 668-670
8. Shibata, H. et al. (1997) Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science 278, 120-123
9. Yeung, A.T. et al. (2008) One-hit effects in cancer: altered proteome of morphologically normal colon crypts in familial adenomatous polyposis. Cancer Res. 68, 7579-7586
10. Todaro, M. et al. (2010) Colon cancer stem cells: promise of targeted therapy. Gastroenterology 138, 2151-2162
11. Barker, N. et al. (2009) Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457, 608-611
12. Kolls, J.K. and Linden, A. (2004) Interleukin-17 family members and inflammation. Immunity 21, 467-476 (Pubitemid 39370503)
13. Fossiez, F. et al. (1996) T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J. Exp. Med. 183, 2593-2603 (Pubitemid 26193037)
14. Gaffen, S.L. (2009) Structure and signalling in the IL-17 receptor family. Nat. Rev. Immunol. 9, 556-567
15. Zou, W. and Restifo, N.P. (2010) T(H)17 cells in tumour immunity and immunotherapy. Nat. Rev. Immunol. 10, 248-256
16. Zepp, J. et al. (2011) IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease. Trends Immunol. 32, 232-239
17. Iwakura, Y. et al. (2011) Functional specialization of interleukin-17 family members. Immunity 34, 149-162
18. Ishigame, H. et al. (2009) Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 30, 108-119
19. Leppkes, M. et al. (2009) RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. Gastroenterology 136, 257-267
20. O'Connor, W., Jr et al. (2009) A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat. Immunol. 10, 603-609
21. Annunziato, F. et al. (2007) Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204, 1849-1861 (Pubitemid 47240944)
22. Ito, R. et al. (2008) Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice. Biochem. Biophys. Res. Commun. 377, 12-16
23. Ogawa, A. et al. (2004) Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin. Immunol. 110, 55-62 (Pubitemid 38177420)
24. Yang, X.O. et al. (2008) Regulation of inflammatory responses by IL-17F. J. Exp. Med. 205, 1063-1075 (Pubitemid 351679682)
25. Rakoff-Nahoum, S. and Medzhitov, R. (2007) Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 317, 124-127 (Pubitemid 47056471)
26. Chae, W-J. et al. (2010) Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis. Proc. Natl. Acad. Sci. U. S. A. 107, 5540-5544
27. Wu, S. et al. (2009) A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 15, 1016-1022
28. Baltgalvis, K.A. et al. (2008) Interleukin-6 and cachexia in ApcMin/+ mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R393-R401
29. Zheng, Y. and Rudensky, A.Y. (2007) Foxp3 in control of the regulatory T cell lineage. Nat. Immunol. 8, 457-462 (Pubitemid 46605910)
30. Kryczek, I. et al. (2009) Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 114, 1141-1149
31. Stagg, J. and Smyth, M.J. (2010) Extracellular adenosine triphosphate and adenosine in cancer. Oncogene 29, 5346-5358
32. Zhang, B. et al. (2008) The prevalence of Th17 cells in patients with gastric cancer. Biochem. Biophys. Res. Commun. 374, 533-537
33. Zhang, J.P. et al. (2009) Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J. Hepatol. 50, 980-989
34. Wang, L. et al. (2010) IL-17 enhances tumor development in carcinogeninduced skin cancer. Cancer Res. 70, 10112-10120
35. Su, X. et al. (2010) Tumor microenvironments direct the recruitment and expansion of human Th17 cells. J. Immunol. 184, 1630-1641
36. Prabhala, R.H. et al. (2010) Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma. Blood 115, 5385-5392
37. Kryczek, I. et al. (2011) IL-17(+) regulatory T cells in the microenvironments of chronic inflammation and cancer. J. Immunol. 186, 4388-4395
38. Erdman, S.E. et al. (2005) CD4+CD25+ regulatory lymphocytes induce regression of intestinaltumors inApcMin/+mice.Cancer Res. 65, 3998-4004 (Pubitemid 40775635)
39. Wilke, C.M. et al. (2011) Th17 cells in cancer: help or hindrance? Carcinogenesis 32, 643-649
40. Chae, W-J. and Bothwell, A.L.M. (2011) IL-17F deficiency inhibits small intestinal tumorigenesis in Apc/Min+ mice. Biochem. Biophys. Res. Commun. 414, 31-36